The selective inhibitors of GSDMD, inflammasomes, and caspase-1 are identified to ameliorate inflammation and thrombosis, and some of them exhibit excellent therapeutic efficacy in several autoimmune diseases. The gene discussed is GSDMD; the disease is autoimmune disease.